Skip to Content
November 21, 2024 Rain | 46°F
The 193rd General Court of the Commonwealth of Massachusetts

Bill S.1048 189th (2015 - 2016)

An Act to promote transparency and cost control of pharmaceutical drug prices

By Mr. Montigny, a petition (accompanied by bill, Senate, No. 1048) of Mark C. Montigny, Jason M. Lewis, James B. Eldridge, Michael O. Moore and other members of the General Court for legislation to promote transparency and cost control of pharmaceutical drug prices. Mental Health and Substance Abuse.

Bill Information

Presenter:
Mark C. Montigny

Bill History

Displaying 9 actions for Bill S.1048
Date Branch Action
4/15/2015 Senate Referred to the committee on Mental Health and Substance Abuse
4/15/2015 House House concurred
9/10/2015 Senate Discharged to the committee on Health Care Financing
9/14/2015 House House concurred
2/12/2016 Joint Hearing scheduled for 03/22/2016 from 11:00 AM-04:00 PM in Gardner Auditorium
3/16/2016 Joint Hearing canceled – new hearing TBD
4/29/2016 Senate Reporting date extended to Wednesday June 1, 2016, pending concurrence
5/2/2016 House Adopted, in concurrence
6/2/2016 Senate Accompanied a study order, see S2307

The information contained in this website is for general information purposes only. The General Court provides this information as a public service and while we endeavor to keep the data accurate and current to the best of our ability, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.